Bioaffinity Technologies Inc (BIAF)

$7.95 -1.44 (-15.34%)
Market Cap 4.78M
Revenue (ttm) 6.16M
Net Income (ttm) -14.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -242.05%
Debt to Equity Ratio 0.02
Volume 827,800
Avg Vol 3,188,947
Day's Range N/A - N/A
Shares Out 601,000.00
Stochastic %K 21%
Beta -1.11
Analysts Strong Buy
Price Target $6.00

Company Profile

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indica...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 210 698 5334
Address:
3300 Nacogdoches Road, Suite 216, San Antonio, United States
TALENT_ON_LOAN_FROM_GOD
TALENT_ON_LOAN_FROM_GOD Sep. 13 at 2:42 PM
$BDRX $BIAF $TNON $TRUG WE CAN PLAY WITH THESE NUMBERS BUT SOMETHING TO CHEW ON *****TRUG******
0 · Reply
Jihooniihf
Jihooniihf Sep. 12 at 11:26 AM
$BIAF what should I do guys…
3 · Reply
TALENT_ON_LOAN_FROM_GOD
TALENT_ON_LOAN_FROM_GOD Sep. 12 at 12:53 AM
$TRUG ,,,,,,,🚨HAVE A GOOD WEEKEND TEAM 🥃 TRUG IS SOLID $1 BREAK LIKELY MONDAY $BDRX BIG WIN $TNON Big win. Unfortunately☝️corrupt mgmt decided to free shorty before we could maintain double digit status like our $BIAF
1 · Reply
vvvvvvrebel89130
vvvvvvrebel89130 Sep. 11 at 8:21 PM
$BIAF 5 minute standard presentation
0 · Reply
AlwaysABullNeverABear
AlwaysABullNeverABear Sep. 11 at 7:57 PM
$BIAF 12 AH
0 · Reply
equity_jar
equity_jar Sep. 11 at 7:26 PM
$FGL 👀 $TNON $BIAF $SMCI $OKLO 🍿💚🤑
1 · Reply
Baazigar123
Baazigar123 Sep. 11 at 7:00 PM
$BIAF SXTC
0 · Reply
pedro_333
pedro_333 Sep. 11 at 6:00 PM
$BIAF tuesday and wednesday will be for talks with investors. I wouldn't be out of here until next thursday, but that's me ✌️
0 · Reply
pedro_333
pedro_333 Sep. 11 at 5:57 PM
$BIAF the CEO is going to talk and make a presentation next monday morning at 8am. Don't mind the little correction today, monday 's pre market will be a good one
0 · Reply
AlwaysABullNeverABear
AlwaysABullNeverABear Sep. 11 at 5:57 PM
$BIAF would be great to finish green
0 · Reply
Latest News on BIAF
bioAffinity Technologies Transcript: H.C. Wainwright 28th Annual Global Investment Conference

Sep 11, 2026, 7:00 AM EDT - 2 days ago

bioAffinity Technologies Transcript: H.C. Wainwright 28th Annual Global Investment Conference

BioAffinity Technologies regains compliance with Nasdaq listing requirements

2026-09-09T12:15:15.000Z - 4 days ago

BioAffinity Technologies regains compliance with Nasdaq listing requirements

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements

Sep 9, 2026, 8:00 AM EDT - 4 days ago

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements

bioAffinity Technologies Inc trading resumes

2026-09-04T15:15:40.000Z - 9 days ago

bioAffinity Technologies Inc trading resumes

bioAffinity Technologies Inc trading halted, volatility trading pause

2026-09-04T15:10:20.000Z - 9 days ago

bioAffinity Technologies Inc trading halted, volatility trading pause

bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Sep 3, 2026, 4:30 PM EDT - 10 days ago

bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

bioAffinity Technologies Registration statement: Registration filing

Sep 3, 2026, 8:00 AM EDT - 10 days ago

bioAffinity Technologies Registration statement: Registration filing

Why Is Penny Stock BioAffinity Technologies (BIAF) Up Today?

2026-09-01T13:39:13.000Z - 12 days ago

Why Is Penny Stock BioAffinity Technologies (BIAF) Up Today?

BioAffinity Technologies advances CyPath Lung for cancer survivor surveillance

2026-09-01T12:11:14.000Z - 12 days ago

BioAffinity Technologies advances CyPath Lung for cancer survivor surveillance

bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors

Sep 1, 2026, 8:00 AM EDT - 12 days ago

bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors

BioAffinity Technologies files to sell 1.71M shares of common stock for holders

2026-08-27T20:35:20.000Z - 17 days ago

BioAffinity Technologies files to sell 1.71M shares of common stock for holders

bioAffinity Technologies Registration statement: Registration filing

Aug 27, 2026, 8:00 AM EDT - 17 days ago

bioAffinity Technologies Registration statement: Registration filing

bioAffinity Technologies Inc trading halted, news pending

2026-08-21T23:55:08.000Z - 22 days ago

bioAffinity Technologies Inc trading halted, news pending

BioAffinity Technologies announces 1-for-15 reverse stock split

2026-08-20T12:05:09.000Z - 24 days ago

BioAffinity Technologies announces 1-for-15 reverse stock split

bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026

Aug 20, 2026, 8:00 AM EDT - 24 days ago

bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026

BioAffinity Technologies, AvMEDICAL announce distribution agreement for CyPath

2026-08-18T12:05:35.000Z - 26 days ago

BioAffinity Technologies, AvMEDICAL announce distribution agreement for CyPath

bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung

Aug 18, 2026, 8:00 AM EDT - 26 days ago

bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung

BioAffinity prices 8.46M shares at 47.27c in private placement

2026-08-17T07:36:26.000Z - 27 days ago

BioAffinity prices 8.46M shares at 47.27c in private placement

BioAffinity Technologies announces closing of $4M private placement offering

2026-08-16T13:00:19.000Z - 4 weeks ago

BioAffinity Technologies announces closing of $4M private placement offering

WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Aug 14, 2026, 11:45 AM EDT - 4 weeks ago

WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Aug 14, 2026, 11:07 AM EDT - 4 weeks ago

bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Aug 13, 2026, 10:00 AM EDT - 4 weeks ago

WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Aug 13, 2026, 9:07 AM EDT - 4 weeks ago

bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

bioAffinity Technologies Earnings release: Q2 2026

Aug 7, 2026, 8:30 AM EDT - 5 weeks ago

bioAffinity Technologies Earnings release: Q2 2026

bioAffinity Technologies Quarterly report: Q2 2026

Aug 7, 2026, 8:30 AM EDT - 5 weeks ago

bioAffinity Technologies Quarterly report: Q2 2026

BioAffinity Technologies reports Q2 EPS (64c) vs ($5.07) last year

2026-08-07T12:06:04.000Z - 5 weeks ago

BioAffinity Technologies reports Q2 EPS (64c) vs ($5.07) last year

bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung

Aug 7, 2026, 8:00 AM EDT - 5 weeks ago

bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung

BioAffinity announces publication of clinical review on CyPath Lung

2026-07-27T12:15:08.000Z - 6 weeks ago

BioAffinity announces publication of clinical review on CyPath Lung

bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung

Jul 27, 2026, 8:08 AM EDT - 6 weeks ago

bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung

BioAffinity Technologies announces collaboration with Pictor

2026-07-22T12:16:50.000Z - 7 weeks ago

BioAffinity Technologies announces collaboration with Pictor

bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity's Diagnostics for Asthma and COPD

Jul 22, 2026, 8:08 AM EDT - 7 weeks ago

bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity's Diagnostics for Asthma and COPD

BioAffinity Technologies’ CyPath Lung diagnostic sales double in Q2

2026-07-07T12:55:34.000Z - 2 months ago

BioAffinity Technologies’ CyPath Lung diagnostic sales double in Q2

bioAffinity Technologies' Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues

Jul 7, 2026, 8:46 AM EDT - 2 months ago

bioAffinity Technologies' Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues

BioAffinity will present preclinical findings on small interfering RNAs

2026-06-22T12:09:49.000Z - 2 months ago

BioAffinity will present preclinical findings on small interfering RNAs

bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

Jun 22, 2026, 8:00 AM EDT - 2 months ago

bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

Jun 18, 2026, 2:54 PM EDT - 2 months ago

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering

bioAffinity Technologies Announces Closing of $3.2 Million Offering

Jun 18, 2026, 1:16 PM EDT - 2 months ago

bioAffinity Technologies Announces Closing of $3.2 Million Offering

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering

Jun 17, 2026, 10:41 AM EDT - 2 months ago

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering

bioAffinity Technologies Announces Pricing of $3.2 Million Offering

Jun 17, 2026, 9:25 AM EDT - 2 months ago

bioAffinity Technologies Announces Pricing of $3.2 Million Offering

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

Jun 16, 2026, 8:06 AM EDT - 2 months ago

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

bioAffinity Technologies Registration statement: Registration filing

Jun 16, 2026, 8:00 AM EDT - 2 months ago

bioAffinity Technologies Registration statement: Registration filing

bioAffinity Technologies Registration statement: Registration filing

Jun 12, 2026, 8:00 AM EDT - 3 months ago

bioAffinity Technologies Registration statement: Registration filing

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies' Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar

Jun 2, 2026, 8:00 AM EDT - 3 months ago

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies' Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar

bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology

May 27, 2026, 8:00 AM EDT - 3 months ago

bioAffinity Technologies Announces Notification of Mexico Patent Allowance Covering Novel Lung Cancer Detection Methods Using CyPath® Lung Technology

bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026

May 12, 2026, 9:15 AM EDT - 4 months ago

bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung

May 8, 2026, 8:30 AM EDT - 4 months ago

bioAffinity Technologies Reports First Quarter 2026 Results and Expanding Adoption and Clinical Usage of CyPath® Lung

bioAffinity Technologies Earnings release: Q1 2026

May 8, 2026, 8:30 AM EDT - 4 months ago

bioAffinity Technologies Earnings release: Q1 2026

bioAffinity Technologies Quarterly report: Q1 2026

May 8, 2026, 8:30 AM EDT - 4 months ago

bioAffinity Technologies Quarterly report: Q1 2026

bioAffinity Technologies Registration statement: Registration filing

Apr 30, 2026, 8:00 AM EDT - 4 months ago

bioAffinity Technologies Registration statement: Registration filing

bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment

Apr 28, 2026, 9:16 AM EDT - 4 months ago

bioAffinity Technologies Launches New Study To Expand Use of CyPath® Lung Technology for Asthma and COPD Diagnosis and Treatment

New Case Study: bioAffinity Technologies' CyPath® Lung Diagnostic Supports Physician's Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy

Apr 14, 2026, 8:00 AM EDT - 5 months ago

New Case Study: bioAffinity Technologies' CyPath® Lung Diagnostic Supports Physician's Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy

bioAffinity Technologies Transcript: Status update

Apr 8, 2026, 7:00 PM EDT - 5 months ago

bioAffinity Technologies Transcript: Status update

bioAffinity Technologies' CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16

Apr 7, 2026, 8:00 AM EDT - 5 months ago

bioAffinity Technologies' CyPath® Lung to Be Featured at Cleveland Clinic Annual “Advances in Early Lung Cancer Detection” Symposium April 16

bioAffinity Technologies' CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026

Apr 1, 2026, 8:00 AM EDT - 5 months ago

bioAffinity Technologies' CyPath® Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026

bioAffinity Technologies Slides: Investor presentation

Mar 26, 2026, 8:00 AM EDT - 5 months ago

bioAffinity Technologies Slides: Investor presentation

bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice

Mar 25, 2026, 8:00 AM EDT - 5 months ago

bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice

New Case Study: bioAffinity Technologies' CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures

Mar 17, 2026, 7:45 AM EDT - 6 months ago

New Case Study: bioAffinity Technologies' CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures

bioAffinity Technologies Proxy statement: Proxy Filing

Mar 16, 2026, 8:00 AM EDT - 6 months ago

bioAffinity Technologies Proxy statement: Proxy Filing

bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung

Mar 13, 2026, 8:00 AM EDT - 6 months ago

bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung

bioAffinity Technologies Annual report: Q4 2025

Mar 13, 2026, 8:00 AM EDT - 6 months ago

bioAffinity Technologies Annual report: Q4 2025

bioAffinity Technologies Earnings release: Q4 2025

Mar 13, 2026, 8:00 AM EDT - 6 months ago

bioAffinity Technologies Earnings release: Q4 2025

bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic

Mar 10, 2026, 7:47 AM EDT - 6 months ago

bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic

bioAffinity Technologies Proxy statement: Proxy Filing

Mar 5, 2026, 7:00 AM EST - 6 months ago

bioAffinity Technologies Proxy statement: Proxy Filing

bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients

Mar 3, 2026, 8:30 AM EST - 6 months ago

bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients

bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test

Feb 25, 2026, 8:30 AM EST - 6 months ago

bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath® Lung Noninvasive Early Detection Lung Cancer Test

New Case Study Highlights Ability of bioAffinity Technologies' CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer

Feb 19, 2026, 11:00 AM EST - 6 months ago

New Case Study Highlights Ability of bioAffinity Technologies' CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer

Clinical Utility of bioAffinity Technologies' CyPath® Lung Test Demonstrated in Real-World Case Study

Feb 17, 2026, 8:00 AM EST - 6 months ago

Clinical Utility of bioAffinity Technologies' CyPath® Lung Test Demonstrated in Real-World Case Study

bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board

Feb 9, 2026, 8:00 AM EST - 7 months ago

bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board

bioAffinity Technologies' Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation

Jan 7, 2026, 8:00 AM EST - 8 months ago

bioAffinity Technologies' Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation

bioAffinity Technologies' Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable

Dec 3, 2025, 8:00 AM EST - 9 months ago

bioAffinity Technologies' Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable

bioAffinity Technologies Quarterly report: Q3 2025

Nov 14, 2025, 8:30 AM EST - 10 months ago

bioAffinity Technologies Quarterly report: Q3 2025

bioAffinity Technologies Earnings release: Q3 2025

Nov 14, 2025, 8:30 AM EST - 10 months ago

bioAffinity Technologies Earnings release: Q3 2025

bioAffinity Technologies Reports Third Quarter 2025 Financial Results

Nov 14, 2025, 8:00 AM EST - 10 months ago

bioAffinity Technologies Reports Third Quarter 2025 Financial Results

bioAffinity Technologies Proxy statement: Proxy Filing

Nov 12, 2025, 7:00 AM EST - 10 months ago

bioAffinity Technologies Proxy statement: Proxy Filing

bioAffinity Technologies Proxy statement: Proxy Filing

Nov 7, 2025, 7:00 AM EST - 10 months ago

bioAffinity Technologies Proxy statement: Proxy Filing

bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume

Nov 5, 2025, 8:00 AM EST - 10 months ago

bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

Oct 28, 2025, 8:00 AM EDT - 10 months ago

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

bioAffinity Technologies Proxy statement: Proxy Filing

Oct 27, 2025, 8:00 AM EDT - 10 months ago

bioAffinity Technologies Proxy statement: Proxy Filing

bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025

Oct 20, 2025, 8:00 AM EDT - 10 months ago

bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

Oct 16, 2025, 8:00 AM EDT - 11 months ago

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 9, 2025, 2:00 PM EDT - 11 months ago

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 9, 2025, 1:00 PM EDT - 11 months ago

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 8, 2025, 4:15 PM EDT - 11 months ago

WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 8, 2025, 3:45 PM EDT - 11 months ago

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies Proxy statement: Proxy Filing

Oct 8, 2025, 8:00 AM EDT - 11 months ago

bioAffinity Technologies Proxy statement: Proxy Filing

bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025

Oct 7, 2025, 8:00 AM EDT - 11 months ago

bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025

WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m

Sep 30, 2025, 12:44 PM EDT - 11 months ago

WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m

bioAffinity Technologies Announces Closing of $4.8 Million Public Offering

Sep 30, 2025, 12:15 PM EDT - 11 months ago

bioAffinity Technologies Announces Closing of $4.8 Million Public Offering

TALENT_ON_LOAN_FROM_GOD
TALENT_ON_LOAN_FROM_GOD Sep. 13 at 2:42 PM
$BDRX $BIAF $TNON $TRUG WE CAN PLAY WITH THESE NUMBERS BUT SOMETHING TO CHEW ON *****TRUG******
0 · Reply
Jihooniihf
Jihooniihf Sep. 12 at 11:26 AM
$BIAF what should I do guys…
3 · Reply
TALENT_ON_LOAN_FROM_GOD
TALENT_ON_LOAN_FROM_GOD Sep. 12 at 12:53 AM
$TRUG ,,,,,,,🚨HAVE A GOOD WEEKEND TEAM 🥃 TRUG IS SOLID $1 BREAK LIKELY MONDAY $BDRX BIG WIN $TNON Big win. Unfortunately☝️corrupt mgmt decided to free shorty before we could maintain double digit status like our $BIAF
1 · Reply
vvvvvvrebel89130
vvvvvvrebel89130 Sep. 11 at 8:21 PM
$BIAF 5 minute standard presentation
0 · Reply
AlwaysABullNeverABear
AlwaysABullNeverABear Sep. 11 at 7:57 PM
$BIAF 12 AH
0 · Reply
equity_jar
equity_jar Sep. 11 at 7:26 PM
$FGL 👀 $TNON $BIAF $SMCI $OKLO 🍿💚🤑
1 · Reply
Baazigar123
Baazigar123 Sep. 11 at 7:00 PM
$BIAF SXTC
0 · Reply
pedro_333
pedro_333 Sep. 11 at 6:00 PM
$BIAF tuesday and wednesday will be for talks with investors. I wouldn't be out of here until next thursday, but that's me ✌️
0 · Reply
pedro_333
pedro_333 Sep. 11 at 5:57 PM
$BIAF the CEO is going to talk and make a presentation next monday morning at 8am. Don't mind the little correction today, monday 's pre market will be a good one
0 · Reply
AlwaysABullNeverABear
AlwaysABullNeverABear Sep. 11 at 5:57 PM
$BIAF would be great to finish green
0 · Reply
Swihart_Art
Swihart_Art Sep. 11 at 5:55 PM
$BIAF on sale... fair market value about $11... super low float...
1 · Reply
TALENT_ON_LOAN_FROM_GOD
TALENT_ON_LOAN_FROM_GOD Sep. 11 at 5:53 PM
$TRUG IF WE GO $1 SHORTY……TODAY?? KISS YOUR ASS BYE BYE ON MY DEAD HOMIES ☝️🫪 $BDRX $BIAF $TNON —MONEYMADE
0 · Reply
Vicenvicen
Vicenvicen Sep. 11 at 4:52 PM
$BIAF Gap of $ 8.93 closes. Up, up, up.
1 · Reply
Vicenvicen
Vicenvicen Sep. 11 at 4:49 PM
$BIAF It has already closes the gap, now it should rise significantly.
0 · Reply
TALENT_ON_LOAN_FROM_GOD
TALENT_ON_LOAN_FROM_GOD Sep. 11 at 3:55 PM
$TRUG COULD WE BE LOOKING AT 10 BAGGER???? . 57 $BDRX told ya $TNON $BIAF Monsters
0 · Reply
XXTraderXX
XXTraderXX Sep. 11 at 3:45 PM
$BIAF if it can go to 7$ i will load the shit out of it lol
0 · Reply
TALENT_ON_LOAN_FROM_GOD
TALENT_ON_LOAN_FROM_GOD Sep. 11 at 3:43 PM
$TNON ALMOST THERE!!! WHO’S YOUR DADDY!!!!! DOUBLE DIGITS RUNNER LIKE MY $BIAF —MONEYMADE
1 · Reply
Swihart_Art
Swihart_Art Sep. 11 at 3:42 PM
$BIAF
0 · Reply
Baazigar123
Baazigar123 Sep. 11 at 3:12 PM
$BIAF meme junk
0 · Reply
Swihart_Art
Swihart_Art Sep. 11 at 3:10 PM
$BIAF all in at 8...
0 · Reply
Jihooniihf
Jihooniihf Sep. 11 at 2:32 PM
$BIAF fuck
0 · Reply
AlwaysABullNeverABear
AlwaysABullNeverABear Sep. 11 at 2:14 PM
$BIAF shithouse
0 · Reply